John A. Kairalla - Concepedia

Author

John A. Kairalla

Also Known As

Hall, Allyson, J. A. Kairalla, J. Kairalla, John A Kairalla, John A. Kairalla, John Kairalla, Kairalla, John, Kairalla, John Andrew, Kneipp, Shawn M., Muller, Keith E.

109

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Florida The University of Texas Southwestern Medical Center St. Jude Children's Research Hospital University of Alabama at Birmingham Children's Hospital of Philadelphia

About

John A. Kairalla is an author at University of Florida specializing in medicine, pediatrics, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	599
2	Health Sciences	6	6	356
3	Education	1	1	63
4	Engineering	1	1	10
5	Nursing	1	1	16

John A. Kairalla

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622 William B. Slayton, Kirk R. Schultz, John A. Kairalla, Journal of Clinical Oncology Young AdultsContinuous ImatinibMyeloid NeoplasiaHematological MalignancyNeuro-oncology	2018	242
Longitudinal Changes in Bone Density in Children and Adolescents with Moderate to Severe Cerebral Palsy Richard C. Henderson, John A. Kairalla, John W. Barrington, The Journal of Pediatrics Bone DiseaseBone HealthBody CompositionLongitudinal ChangesPediatrics	2005	144
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children Sumit Gupta, Rachel E. Rau, John A. Kairalla, New England Journal of Medicine	2024	131
Predicting low bone density in children and young adults with quadriplegic cerebral palsy Richard C. Henderson, John A. Kairalla, Almas Abbas, Developmental Medicine & Child Neurology	2004	116
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932 Anne Angiolillo, Reuven J. Schore, John A. Kairalla, Journal of Clinical Oncology	2021	93
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 Patrick A. Brown, John A. Kairalla, Joanne M. Hilden, Leukemia Hematological MalignancyPediatric HematologyMedicineFlt3 Inhibitor LestaurtinibHematology	2021	88
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study AALL1131 Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Journal of Clinical Oncology	2020	77
<b>GLUMIP</b>2.0:<i>SAS/IML</i>Software for Planning Internal Pilots John A. Kairalla, Christopher S. Coffey, Keith E. Muller Journal of Statistical Software	2008	71
Relationship between the number of behavioral symptoms in dementia and caregiver distress: what is the tipping point? Paul Arthur, Laura N. Gitlin, John A. Kairalla, International Psychogeriatrics	2017	64
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials Sumit Gupta, Yunfeng Dai, Zhiguo Chen, The Lancet Haematology EthnicityLymphoid NeoplasiaEthnic DisparitiesHematological MalignancyCancer Epidemiology	2023	63

Page 1